Filing Details
- Accession Number:
- 0001209191-22-051665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-30 17:11:32
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2022-09-30 17:11:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-16 | 110 | $2.35 | 194,010 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-17 | 110 | $2.31 | 194,120 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-18 | 110 | $2.23 | 194,230 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-19 | 110 | $2.35 | 194,340 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-22 | 110 | $2.51 | 194,450 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-23 | 110 | $2.59 | 194,560 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-24 | 110 | $2.59 | 194,670 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-25 | 110 | $2.62 | 194,780 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-26 | 110 | $2.55 | 194,890 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-29 | 115 | $2.44 | 195,005 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-30 | 115 | $2.38 | 195,120 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-31 | 115 | $2.36 | 195,235 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-01 | 115 | $2.39 | 195,350 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-02 | 115 | $2.42 | 195,465 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-06 | 115 | $2.15 | 195,580 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-07 | 115 | $2.24 | 195,695 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-08 | 115 | $2.22 | 195,810 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-09 | 60 | $2.21 | 195,870 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-12 | 115 | $2.46 | 195,985 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-13 | 115 | $2.45 | 196,100 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-14 | 115 | $2.51 | 196,215 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-15 | 115 | $2.47 | 196,330 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-16 | 115 | $2.49 | 196,445 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-19 | 105 | $2.56 | 196,550 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-20 | 105 | $2.54 | 196,655 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-21 | 105 | $2.59 | 196,760 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-22 | 105 | $2.51 | 196,865 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-23 | 105 | $2.55 | 196,970 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-26 | 105 | $2.49 | 197,075 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-27 | 105 | $2.57 | 197,180 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.